ScopeSys

ScopeSys

Biotechnology

Vancouver, BC 435 followers

CLiC, single-molecule imaging

About us

ScopeSys is a dynamic startup that partners with pharmaceutical companies to bring single molecule imaging to the next level. Our unique Convex Lens-induced Confinement (CLiC) platform helps access crucial information for drug and vaccines delivery without the need for tethering chemistry.

Website
https://www.scopesys.ca/
Industry
Biotechnology
Company size
2-10 employees
Headquarters
Vancouver, BC
Type
Privately Held
Founded
2017
Specialties
Single-molecule imaging, Biotechnology, Nanotechnology, Optical sensing, and Nanobioscience

Locations

Employees at ScopeSys

Updates

  • View organization page for ScopeSys, graphic

    435 followers

    🌟Reflecting on 2023: A Year of Milestones at ScopeSys🌟 As we dive into the new year, let's take a moment to celebrate the remarkable achievements of 2023 and extend our heartfelt gratitude to all our collaborators in the nanomedicine space. Your dedication and partnership continue to propel us forward. 🏆 #ScopeSys has been recognized as a "Company to Watch" by Life Sciences BC in its 25th anniversary edition. Sharing this accolade with esteemed peers like #BoldTherapeuticsInc.,#GandeevaTherapeutics, and #SonicIncytesMedicalCorp. underscores the impactful strides we've made as an early-stage company. This recognition inspires us to push boundaries and innovate even further. 💡 Securing a coveted spot at the #SBME Innovates incubator within UBC's Biomedical Research Center marks a significant milestone in our journey. This incubator is a hub for biotech innovation, providing invaluable resources to accelerate our growth and amplify our impact. We're eager to leverage this opportunity as we continue to scale up and drive positive change in the industry. 🔬 Exciting news on the research front! Our CLiC microscopy imaging system has been prominently featured in a recent publication co-authored with #LeslieLab and #CullisLab. Titled "Determination of the interior pH of lipid nanoparticles using a pH-sensitive fluorescent dye-based DNA probe," this study showcases the cutting-edge capabilities of our technology. Dive into the details of our groundbreaking research: https://lnkd.in/d5QN_zn9. Together, these achievements epitomize our commitment to advancing nanomedicine and revolutionizing healthcare. As we embark on the journey ahead, let's carry forward the spirit of collaboration, innovation, and excellence that defines ScopeSys.

    • No alternative text description for this image
  • View organization page for ScopeSys, graphic

    435 followers

    ScopeSys was delighted to be a part of the NMIN 2024 Research Conference held in Vancouver this past week. 🌟 This dynamic gathering brought together an exceptional assembly of scientific leaders, researchers, trainees, as well as representatives from industry and non-profit organizations, embodying the vibrant Canadian Nanomedicines ecosystem. The event provided an excellent platform to engage with participants, fostering discussions on the latest breakthroughs, emerging trends, and key priorities within the Nanomedicines landscape. Connecting with like-minded professionals not only enriched our understanding but also fueled our commitment to driving advancements ni this transformative field. 🚀 #NMIN #NMIN2024conference #ScopeSys #Nanomedicine #NanomedicinesinCanada

    • No alternative text description for this image

Similar pages

Browse jobs